Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Current Advances in Therapeutic Peptides: Past and Future Trends

Version 1 : Received: 4 February 2021 / Approved: 10 February 2021 / Online: 10 February 2021 (15:51:13 CET)

How to cite: Chelliah, R.; Daliri, E.B.; Elahi, F.; Yeon, S.; Tyagi, A.; Oh, D. Current Advances in Therapeutic Peptides: Past and Future Trends . Preprints 2021, 2021020265 (doi: 10.20944/preprints202102.0265.v1). Chelliah, R.; Daliri, E.B.; Elahi, F.; Yeon, S.; Tyagi, A.; Oh, D. Current Advances in Therapeutic Peptides: Past and Future Trends . Preprints 2021, 2021020265 (doi: 10.20944/preprints202102.0265.v1).

Abstract

The treatment of peptides has played an important role in clinical practice since the discovery of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States (US and other regional mar-kets, and peptides continue to undergo drug discovery steadily. Peptide research and development has lev-eraged a wider range of structures known from other plant sources, via pharmacology and medicinal molecular biology, beyond its conventional focus on individual endogenous peptides. We build a comprehensive database of peptides that have met scientific studies with more than 150 constantly evolving peptides. Here we provide a simple overview of the peptide-based drug therapy environment, comprising evolutionary points of view, structural properties, operational thresholds, and explanation of the therapeutic area.

Subject Areas

Peptides; Clinical Practice; Drug Therapy; Therapeutic

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.